Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance

SIMPLE SUMMARY: In the last decades, identification of the factors/mechanisms leading to cancer development has advanced the way clinicians combat this pathology. Indeed, the use of adjuvant chemotherapies and targeted therapies has markedly contributed to prolonging the survival of cancer patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Monteleone, Giovanni, Franzè, Eleonora, Maresca, Claudia, Colella, Marco, Pacifico, Teresa, Stolfi, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913481/
https://www.ncbi.nlm.nih.gov/pubmed/36765929
http://dx.doi.org/10.3390/cancers15030971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913481/
https://www.ncbi.nlm.nih.gov/pubmed/36765929
http://dx.doi.org/10.3390/cancers15030971

Ejemplares similares